01
InnerCell™
Nanocapsule delivery
ECM-mimicking nanocapsules release actives layer by layer for deeper, sustained delivery.
- ECM-mimetic capsules
- Sequential release
- Growth-factor delivery
Regenerative Aesthetics · Bio-Pharmaceutical Innovation
Devices, injectables and medical-grade skincare built on innovation and research.
3D-molded barbed and mesh threads for lift and fixation.
D+ and R+ formulae, tested against control in fibroblast assays.
One-step implanter that creates the recipient site and places the graft in a single motion.
Portfolio
Every claim traces to a pathway or a measurable endpoint.
Beyond filling and freezing: signaling and rebuilding.
Assays, tensile data and endpoints, published per product.
Clinical Evidence
Headline results from in-vitro and clinical testing. Full datasets available on request.
Request the dataSpec sheets and clinical dossiers on request.
Six platform technologies behind every FoyBiomed product. One science, one auditable evidence chain.
Nanocapsule delivery
ECM-mimicking nanocapsules release actives layer by layer for deeper, sustained delivery.
Multi-layer hyaluronic acid
Mixed molecular weights hydrate the surface and the deep dermis at once.
Stem-cell conditioned medium
Patented stem-cell medium, standardized to 71 growth factors and 100 growth factors.
14-factor complex
Growth factors, peptides and plant stem-cell extracts that activate fibroblasts and speed tissue repair.
Thread architecture
Molded, not cut, barbs keep their strength. Mesh spreads the load for longer fixation.
Low-friction devices
HA coating and W-type geometry reduce friction, trauma and bruising.
From R&D to Clinic
Growth-factor panels measured per batch
Device geometries tested for tensile strength and degradation
Full dossier for clinicians and partners on request
Products
MINT PLCL/PDO, Klardie Skin Booster and Lion Hair Implanter. Each backed by its own data.
01
3D-molded barbed and mesh threads for lift and fixation.
02
D+ and R+ formulae, tested against control in fibroblast assays.
03
A one-step hair restoration system. The Lion implanter creates the recipient site and places the follicular graft in a single motion.
MINT™Patented Technology
Barbs are press-moulded onto the thread, not cut, and set in a 360° helix to anchor the skin's 3D structure.
MINT™ Mesh · Multi & Bi
Moulded cogs anchor the tissue while the mesh supports it.
Stable hold without displacement.
More tissue contact, more fibroblast activity.
Lift stays consistent over time.
Our Divisions
For Clinicians
Treatment Protocols
| Product / Protocol | Sessions | Interval | Maintenance | Indication area |
|---|---|---|---|---|
| klardie Plus (D+ / R+) | 3–5 sessions | 2–3 weeks apart | Every 3–6 months | Face, neck, décolleté |
| Cellup Solution (Dia / Ruby) | 3–5 sessions | 2–4 weeks apart | Every 4–6 months | Face, periorbital |
| MINT™ Mesh / Mono | Single procedure | Assess at 4 weeks | 12–18 months | Mid-face, jawline, brow |
| Scalp-Repair Protocol | 8–12 weeks course | 2–3 applications / week | Ongoing tonic use | Scalp |
| Active CellPower Mask | Post-procedure + weekly | 1–2x weekly | Adjunct to all protocols | Full face |
| Fusicare Recovery | 7–14 days post-procedure | Daily AM/PM | Transition to Timeless line | Treated zones |
Protocols are starting recommendations; final treatment planning remains at the discretion of the treating physician.
Documentation
Technical specifications, dimensions and composition for every product, matching our printed dossiers.
Contact usFull study reports with methodology, cohorts and statistical analysis.
Contact usRegistration certificates and market-approval status by country.
Contact us
Email us and we will send the documents relevant to your specialty and market.
Contact usAbout FoyBiomed
A regenerative aesthetics company serving plastic surgeons, dermatologists, and aesthetic clinics, with products available in 80+ countries.
FoyBiomed was founded on a single conviction: the future of aesthetics is regenerative, not corrective. We operate as a bio-pharmaceutical company serving aesthetic medicine — developing delivery systems, growth-factor platforms, and procedural devices under pharmaceutical-grade quality systems.
Our research programs begin with cell signaling — fibroblast activation, ECM remodeling, aquaporin expression, follicle environment — and work outward to the formulation or device that can move that pathway in a clinical setting.
ISO 13485 quality management and GMP manufacturing govern every line, from PDO thread molding to conditioned-medium standardization. Batch consistency is a clinical feature, not an operational detail.
Global Reach
Clinical Partnership
Contact
Questions about our products, protocols or documentation? Email us and we will reply within two business days.
For product information, spec sheets, clinical dossiers and partnership enquiries.
Response time
Within two business daysWe reply to every enquiry by email.
Documents available
Spec sheets, dossiers, certificatesProduct specifications, clinical study reports and regulatory documents.
FoyBiomed
This page is being rebuilt next. Its content will follow the approved design.
